Search Results - "Saura Grau, S."

Next generation sequencing (NGS) in melanoma patients: a descriptive study of a Canarian cohort with suspected cutaneous melanoma-dominant syndrome by Castro Gonzalez, E.N., García Miñarro, A., Afonso Medina, M. d. P., González Martín, J.M., Saura Grau, S., Castaño González, I., Carretero Hernández, G.

Get full text

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication by Schneeweiss, A., Peretz-Yablonski, T., Nowecki, Z., Merot, J.-L., Pena-Murillo, C., Bachelot, T., Coudert, B., Nowecki, Z., Wardley, A., Puglisi, F., Montemurro, F., Hu, X., Gaafar, R., Li, H., Aktas, B., Tienghi, A., Miles, D., Lux, M., Menjon Beltran, S., Turner, N., Tong, Z., Boer, K., Horvath, Z., Susnjar, S., Matos, E., Garcia Estevez, L., Cruz, M., Bourgeois, H., von Schumann, R., Morales-Vásques, F., Voitko, N., Hicks, J., Barrett-Lee, P., Wheatley, D., Gozy, M., Latini, L., Barnadas Molins, A., Bratos, R., McCarthy, N., Kee, D., Artignan, X., Azribi, F., Jaafar, H., Augereau, P., Müller, V., Evron, E., Cascinu, S., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Kukulska, M., Levitt, N., Panwar, U., Rigg, A., Fein, L., Malik, L., Singer, C., Stoeger, H., Cedeño, M., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Fried, G., Moscetti, L., Siddiqi, N., Arcediano Del Amo, A., McAdam, K., Dunn, G., Taylor, W., Hegg, R., Grosjean, J., Laplaige, P., Christensen, B., Zahm, D.-M., Inbar, M., Bonetti, A., van der Velden, A., van Warmerdam, L., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Joffe, J., Nobre, A., Jiang, J., Padrik, P., Dohollou, N., Prulhiere, K., Ober, A., Alabiso, O., van de Wouw, A.J., Saadein, A., Abdelhafiez, N., Abulkhair, O., Llorente Domenech, R., Gil Raga, M., Rodriguez Sanchez, C., Torrego Garcia, J., Vicente Rubio, E., Jones, A., Alonso, I.

“…The phase III CLinical Evaluation Of Pertuzumab And TRAstuzumab (CLEOPATRA) trial established the combination of pertuzumab, trastuzumab and docetaxel as…”
Get full text

71P Impact of body mass index (BMI) on pathological complete response (pCR) and survival of breast cancer (BC) patients receiving neoadjuvant chemotherapy (NAC) by Aguiar Bujanda, D., Ros Sanjuan, L., Perez Cabrera, D., Croissier Sanchez, L., Mori De Santiago, M., Hernandez Sosa, M., Vargas Prado, A.M., Galvan Ruiz, S., Antonilli Perez, C., Ten Benajes, R., Fox, B., Martinez Garcia-Cervantes, R., Rubio Romero, G., Hanselmann, R., Saura Grau, S.

Get full text

Clinical activity of rituximab with either CHOP or CVP in MALT lymphoma by Aguiar Bujanda, D., Bohn Sarmiento, U., Saura Grau, S., Rodriguez Franco, C., Aguiar Morales, J.

“…Abstract only e19530 Background: Optimal management of MALT lymphoma remains undeffined. Rituximab has been proven to be an active agent in the treatment of…”
Get full text

Male breast cancer retrospective institution review of a 17-year period by Rodriguez Franco, C., Aguiar Bujanda, D., Saura Grau, S., Bohn Sarmiento, U., Aguiar Morales, J.

“…Abstract only e11638 Background: Male breast cancer (MBC) is a very uncommon illness relative to female breast cancer (FBC) The are some differences between…”
Get full text

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment of primary gastrointestinal B- cell lymphoma by Aguiar Bujanda, D., Cabrera Suárez, M. Á., Llorca Martínez, I., Bohn Sarmiento, U., Saura Grau, S., Rodriguez Franco, C., Aguiar Morales, J.

“…Abstract only…”
Get full text

A-249 - Next generation sequencing (NGS) in melanoma patients: a descriptive study of a Canarian cohort with suspected cutaneous melanoma-dominant syndrome by Castro Gonzalez, E.N., García Miñarro, A., Afonso Medina, M. d. P., González Martín, J.M., Saura Grau, S., Castaño González, I., Carretero Hernández, G.

Get full text